Eutilex Acquires Patent Rights for Cancer Treatment Method
[Asia Economy Reporter Ji Yeon-jin] Eutilex announced on the 19th that it has obtained a patent titled "Anti-human VSIG4 antibodies and uses thereof."
The patent includes anti-human VSIG4 antibodies and their fragments, as well as methods for treating cancer using them.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Despite Warnings of "Do Not Enter, You May Not Make It Out Alive"... Foreign Tourist Stranded After Unauthorized Climb on Jeju Sanbangsan
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The company plans to strengthen its technological competitiveness through the commercialization of this patented technology and the establishment of a global patent portfolio.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
